The European launch of the next-generation WATCHMAN device requires scaling up marketing, sales, and distribution efforts across the region.
Filing excerpt
In the second quarter of 2025, we received CE mark for the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device, which is optimized for healing and designed to improve visualization during device placement and treat a broader range of patient anatomies.
What this signalsFilings often name leadership changes, deals and spending plans.
Technologies
Regions named
sec-10kproductLaunchGet every 10-K signal for Boston Scientific and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Boston Scientific this week?”
The Signal API returns 10-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/cbf1f25e-0d33-4059-92ab-227340dbdb45 returns this record as JSON. POST /v1/companies/enrich returns every signal for bostonscientific.com.
{
"signal_id": "cbf1f25e-0d33-4059-92ab-227340dbdb45",
"signal_type": "sec-10k",
"signal_subtype": "productLaunch",
"detected_at": "2026-02-24T09:19:12.736+00:00",
"company": {
"name": "Boston Scientific",
"domain": "bostonscientific.com"
},
"data": {
"detail": "The European launch of the next-generation WATCHMAN device requires scaling up marketing, sales, and distribution efforts across the region. This creates opportunities for vendors supporting European logistics, multi-language marketing campaigns, and sales enablement for a new product.",
"metrics": {
"timeframe": "current_year"
},
"summary": "Launched WATCHMAN FLX Pro device in Europe after receiving CE mark in Q2 2025.",
"excerpts": "In the second quarter of 2025, we received CE mark for the WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device, which is optimized for healing and designed to improve visualization during device placement and treat a broader range of patient anatomies.",
"relevance": 0.8,
"sentiment": "positive",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/885725/000088572526000010/bsx-20251231.htm",
"filing_date": "2026-02-17",
"filing_year": 2026,
"fiscal_year_end": "12/31",
"sales_relevance": "Go-to-market support",
"signal_category": "strategic",
"regions_mentioned": [
"Europe"
],
"technologies_mentioned": [
"Left Atrial Appendage Closure (LAAC)"
]
}
}
curl https://signals.autobound.ai/v1/signals/cbf1f25e-0d33-4059-92ab-227340dbdb45 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bostonscientific.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.